David Margolis, MD, director of Carolina’s HIV Cure Center, was interviewed by “The Well” on how HIV and SARS-CoV-2 differ, how far the science has evolved since HIV first emerged, and why he’s hopeful about a COVID-19 vaccine.
David Margolis knows viruses. He has spent his career working to eradicate the human immunodeficiency virus (HIV), which causes AIDS. The Sarah Graham Kenan Professor of Medicine, Microbiology and Immunology, and Epidemiology at the UNC School of Medicine, Margolis directs the HIV Cure Center at Carolina, where he and his team pioneered research into one of the most difficult problems in HIV research — how to get the virus out of latency so it can be eliminated and people can be truly cured.
Just this past spring, Carolina inked a second five-year, $20 million deal with the pharmaceutical company ViiV Healthcare Limited — enabling the HIV Cure Center to continue its groundbreaking research. But then a new virus disrupted that work: the global COVID-19 pandemic.
Read the entire interview in the UNC Health and UNC School of Medicine Newsroom.